Navamedic ASA, 21 November 2019: Toril Marie Ås resigns from her position as CFO
in Navamedic ASA ("the Company" or "Navamedic") with effect from 9 December
2019. She will continue to work for the Company for a limited period after this
date to assist the new CFO with relevant transition tasks.
"Navamedic and I would like to thank Toril for her great service to the company,
and especially for her effort relating to the completed demerger and separate
listing of Observe Medical. I wish her all the best for the future," says
Kathrine Gamborg Andreassen, CEO of Navamedic.
For further information, please contact:
Kathrine Gamborg Andreassen, CEO, Navamedic
Mobile: +47 951 78 680
E-mail: kathrine@navamedic.com
About Navamedic ASA:
Navamedic ASA is a full-service provider of high-quality healthcare products to
hospitals and pharmacies. Navamedic meets the specific medical needs of patients
and consumers by leveraging its highly scalable market access platform, leading
category competence and local knowledge. Navamedic is present in all the Nordic
countries, the Baltics and Benelux, with sales representation in the UK and
Greece. Navamedic is headquartered in Oslo, Norway, and listed on the Oslo Stock
Exchange (ticker: NAVA). For more information, please visit www.navamedic.com.